BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 35205796)

  • 1. Immunophenotypic Analysis of Hairy Cell Leukemia (HCL) and Hairy Cell Leukemia-like (HCL-like) Disorders.
    Maitre E; Cornet E; Salaün V; Kerneves P; Chèze S; Repesse Y; Damaj G; Troussard X
    Cancers (Basel); 2022 Feb; 14(4):. PubMed ID: 35205796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deciphering Genetic Alterations of Hairy Cell Leukemia and Hairy Cell Leukemia-like Disorders in 98 Patients.
    Maitre E; Tomowiak C; Lebecque B; Bijou F; Benabed K; Naguib D; Kerneves P; Cornet E; Viailly PJ; Arsham J; Sola B; Jardin F; Troussard X
    Cancers (Basel); 2022 Apr; 14(8):. PubMed ID: 35454811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Single-center Experience in Splenic Diffuse Red Pulp Lymphoma Diagnosis.
    Julhakyan HL; Al-Radi LS; Moiseeva TN; Danishyan KI; Kovrigina AM; Glebova SM; Lugovskaya SA; Dvirnik VN; Khvastunova AN; Yakutik IA; Savchenko VG
    Clin Lymphoma Myeloma Leuk; 2016 Aug; 16 Suppl():S166-9. PubMed ID: 27131623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comprehensive immunophenotypic marker analysis of hairy cell leukemia in paraffin-embedded bone marrow trephine biopsies--a tissue microarray study.
    Tóth-Lipták J; Piukovics K; Borbényi Z; Demeter J; Bagdi E; Krenács L
    Pathol Oncol Res; 2015 Jan; 21(1):203-11. PubMed ID: 24903677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Review on Splenic Diffuse Red Pulp Small B-Cell Lymphoma.
    Yilmaz E; Chhina A; Nava VE; Aggarwal A
    Curr Oncol; 2021 Dec; 28(6):5148-5154. PubMed ID: 34940070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atraumatic Splenic Rupture as an Unusual Presentation of Hairy Cell Leukemia: A Case Report.
    Proskuriakova E; Sakhuja A; Khan S; Shrestha DB; Khosla P
    Cureus; 2023 Jun; 15(6):e40180. PubMed ID: 37431331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hairy Cell Leukemia-Japanese Variant: Report of a Patient and Literature Review.
    Ito M; Harada T; Lang L; Saga T; Kanagawa M; Matsuda R; Yashiro S; Kano S; Sasaki Y; Nakamine H
    Int J Surg Pathol; 2022 Oct; 30(7):828-838. PubMed ID: 35234079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD27-positive hairy cell leukemia-Japanese variant.
    Tabata R; Tabata C; Iwama H; Yasumizu R; Kojima M
    Virchows Arch; 2016 Mar; 468(3):375-9. PubMed ID: 26868143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinguishing hairy cell leukemia variant from hairy cell leukemia: development and validation of diagnostic criteria.
    Shao H; Calvo KR; Grönborg M; Tembhare PR; Kreitman RJ; Stetler-Stevenson M; Yuan CM
    Leuk Res; 2013 Apr; 37(4):401-409. PubMed ID: 23347903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hairy cell leukemia: 2020 update on diagnosis, risk stratification, and treatment.
    Maitre E; Cornet E; Troussard X
    Am J Hematol; 2019 Dec; 94(12):1413-1422. PubMed ID: 31591741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hairy cell leukemia 2018: Update on diagnosis, risk-stratification, and treatment.
    Troussard X; Cornet E
    Am J Hematol; 2017 Dec; 92(12):1382-1390. PubMed ID: 29110361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hairy cell leukemia 2022: Update on diagnosis, risk-stratification, and treatment.
    Troussard X; Maître E; Cornet E
    Am J Hematol; 2022 Feb; 97(2):226-236. PubMed ID: 34710243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hairy cell leukemia 2024: Update on diagnosis, risk-stratification, and treatment-Annual updates in hematological malignancies.
    Troussard X; Maître E; Paillassa J
    Am J Hematol; 2024 Apr; 99(4):679-696. PubMed ID: 38440808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hairy Cell Leukemia: Hematological and Immunophenotypic Profile of 13 Patients.
    Bhatti V; Kaur G; Ahuja A; Isaacs R
    Cureus; 2023 Sep; 15(9):e44876. PubMed ID: 37814728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Untangling hairy cell leukaemia (HCL) variant and other HCL-like disorders: Diagnosis and treatment.
    Troussard X; Maitre E
    J Cell Mol Med; 2024 Feb; 28(3):e18060. PubMed ID: 38095234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis of hairy cell leukemia by flow cytometry.
    Stetler-Stevenson M; Tembhare PR
    Leuk Lymphoma; 2011 Jun; 52 Suppl 2():11-3. PubMed ID: 21504292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel targeted treatments in hairy cell leukemia and other hairy cell-like disorders.
    Maitre E; Paillassa J; Troussard X
    Front Oncol; 2022; 12():1068981. PubMed ID: 36620555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The immunophenotype of hairy cell leukemia (HCL). Proposal for a scoring system to distinguish HCL from B-cell disorders with hairy or villous lymphocytes.
    Matutes E; Morilla R; Owusu-Ankomah K; Houliham A; Meeus P; Catovsky D
    Leuk Lymphoma; 1994; 14 Suppl 1():57-61. PubMed ID: 7820054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunophenotypic variations in hairy cell leukemia.
    Chen YH; Tallman MS; Goolsby C; Peterson L
    Am J Clin Pathol; 2006 Feb; 125(2):251-9. PubMed ID: 16393677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Identification of splenic marginal zone lymphoma from B lymphoproliferative disorders by flow cytometry].
    Hu Y; Chen Y; Wang LH; Chen X; Fang F; Liu SQ; Wu XQ; Zhu P
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Apr; 22(2):349-56. PubMed ID: 24763004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.